Existing investor Septwolves returned as the IoT semiconductor maker secured about $28m that will fuel research and development.

New investors HDI and Nationwide Ventures took part in a series B round that boosted the total raised by the insurance underwriting technology developer to $28m.

OHSU's CNS disorder drug developer has launched with $76m from investors co-led by Arch Venture Partners and Cowen Healthcare Investments.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

LY.com's group buying grocery spinoff raised the money in a Joyy-led round also backed by existing investors including Bertelsmann Asia Investments and Legend Capital.

The fraud prevention software provider closed a series A round co-led by Axa Venture Partners that will support international growth and product development.

Johnson & Johnson Innovation – JJDC returned for Cue Health’s $100m series C round as the medical diagnostics system developer seeks regulatory approval for its Covid-19 test.

The cancer immunotherapy developer's latest round included pharmaceutical producers and co-founders Juno Therapeutics and WuXi AppTec.

The CNS disorder drug developer has launched with $76m from investors including Biogen, Bristol Myers Squibb and Pfizer Ventures.

GV co-led a series C round for the healthcare collaboration service together with F-Prime Capital, Andreessen Horowitz and Transformation Capital, taking its overall funding past $101m.